Member Info for DShox

Regrettably Wolves knows he wrote $400k and in response to some other ID posting $100m. Both numbers likely wide of the mark, each with their own agenda.

Seeing similar behaviour in the US and China. COVID has added urgency to healthcare reform and the industry is looking for better outcomes at lower cost. AI and deep learning is going mainstream.

Oh dear Wolves telling porky pies again. Poor lad.

Several weeks after an LOI expected by the market actually. Exciting times and perhaps more so for IB Neuro, supercharged by StoneChecker. Can't wait to count the multiples of $400k :)

I hear a good fishing boat costs around $400k?

Let him be. He's upset the market is buying up IQAI further from his three failed 4p calls. Hardly qualified to question even the most rampant predictions of £10 :)

I recall David Smith's interview discussing a subscription model for SC being potentially $120k per clinic. I'm perhaps more interested in the royalty part of any deal, which might be transformational to IQAI and its sp.

Question is, how many multiples of Wolves' $400k prediction will it be? Will the sp breach his 10p? - still 100% from here, which will be great news. Anything more, say 20p is a bonus. We can only wait for "RNS day" and all those pesky "rampers" ;)

Hi Wolves. Don't get upset. "You started it" lol

Could be 20p, 25p who knows. 5p is going going...

I'm seeing very little sell appetite and a spread that screams MMs are short of stock. IB Neuro has the power to surprise while we wait for a deal on StoneChecker. Perfect storm?

MMs still got this spread artificially wide. Sell price is above 5p.

Whose "they"? Who makes up this "crew" stating StoneChecker will sell for $100m? There must be loads and loads of them! ;)

Anyway, "they" appear to be holding and accumulating shares quite nicely. "They" were also buying in the 4s and enjoying scooping up all this cheap stock in the 4s and 5s. Those darn "rampers" :)

Don't worry Wolves - unless you've asked LSE to remove your post it's still here. You will recall trying to defend it several times. Don't tell even more fibs. I know you're upset by the sp.

Now the real questions are - can Wolves provide evidence of this "ramping crew" that has been calling 20p on next RNS? I recall one or two exciteable PIs at the most after 5th Aug? How can he say for sure it won't be? What is the next RNS? How does Wolves know when and how much I bought? Has Wolves just admitted he's a "de-ramper"? Has Wolves claimed victory because the spread was 20% (4-5p) at the time he called 4p and the closest one sell got was c.4.20p? Has Wolves lost his mind?

Lol Wolves you never did filter me - you replied the day after to one of my posts lol

Again, just like you denied trolling "4p at open" (even though you posted exactly that 3 hours earlier on the bb)...lets count the multiples of $400k :)

Looks like the market understands IQAI better than you.

Decent day. Everytime Wolves turns up to troll the sp jumps further away from his three separate 4p calls. IB Neuro is looking after itself right now - another tweet today re an auto segmentation breakthrough - they keep coming! It's enough to make you forget StoneChecker LOI signed and I'll be counting the deal in multiples of $400k, being Wolves' prediction - that will be fun. Onwards and upwards.

Artery is a Google backed (AI back-end service provider) award winning platform for FDA approved AI/ML medical solutions. In May it secured $28m which included Temasek of Singapore. I hadn't appreciated that IB Neuro was FDA approved until recently but perhaps equally interesting/important is IB's ability to apply to different body parts and applications, which I imagine means FDA approval for an enormous range of AI diagnostics.

A well researched PI sees huge value at 5.5p and has plenty of "news" to make a judgement. It's at greater risk of drifting upwards actually.

Market players might note there is resistance to close above 5.05p and MMs are aware of historic PI activity at current sp ranges, hence the pause. If PIs hold and buy side volume continues, I see a breakout sticking.

Big growth market as IB Neuro enters its stride and StoneChecker hopefully gets sold to a global major medical group.

A well researched PI understands the opportunity and appreciates the company's improving comms on twitter.